- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about SGMO
Recent news which mentions SGMO
Stocks That Hit 52-Week Lows On Wednesday
December 28, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 22, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
December 21, 2022
From Benzinga
Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment
November 29, 2022
From Benzinga
Earnings Scheduled For November 3, 2022
November 03, 2022
From Benzinga
From Benzinga
Pfizer Resumes Dosing In Phase 3 Hemophilia Gene Therapy Trial Six Months After FDA Lifts Clinical Hold
September 23, 2022
From Benzinga
Under The Hood Of Options Chain Implications — Understanding How Options Data Can Help Inform Investment Decisions
September 20, 2022
From Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 30, 2022
From Benzinga
Sangamo Therapeutics's Return On Capital Employed Insights
August 22, 2022
Tickers
SGMO
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
May 25, 2022
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
April 26, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
April 21, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
April 19, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 15, 2022
From Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
From Benzinga
Sangamo Therapeutics Shares Updated Interim Data From Fabry Disease Gene Therapy Trial
February 08, 2022
Tickers
SGMO
From Benzinga
Stocks That Hit 52-Week Lows On Friday
January 14, 2022
From Benzinga
81 Biggest Movers From Yesterday
November 05, 2021
From Benzinga
Sangamo Therapeutics, inc (SGMO) Q3 2021 Earnings Call Transcript
November 04, 2021
Tickers
SGMO
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.